ImaginAb
VerifiedClinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$51—77m (Dealroom.co estimates Jun 2021.)
Inglewood California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | $0.0 | round | |
| investor investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor investor investor investor | $0.0 | round | |
$12.8m | Late VC | ||
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about ImaginAb
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.